REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/05/2025
Voltar para busca
Dado oficial do USPTO
PHARMID
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
06/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42, 44
Data de depósito
30/06/2017
Data de registro
05/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/05/2020
Última transação
06/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Primeiro uso
04/12/2017
Primeiro uso no comércio
04/12/2017
Código do desenho
4
Tipo de titular
03
Localização do titular
SEATTLE, WA
Examinador
CHARLON, BARNEY
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PHARMID, INC.
PharmID, LLC
Representantes
Daniel M. Wadkins Foster Garvey PC
Classificação técnica
Classes Nice
Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Electro-optical instruments and probes for use in inspection and verification of medication in patient care setting; Computer hardware and software for medical apparatus and instruments used for healthcarefor supporting medication verification and medication inspection; Examination and monitoring equipmentprobes and medication scanners for automated medication identification and medication checking; Downloadable software for use in inspection and verification of medication
Classe 42
Software as a service for hospitalsphysician practiceshealthcare facilitiespatient care settings and clinical research facilities featuring software for inspection and verification of medication and for use in the management of electronic storage of data; Providing temporary use of non-downloadable software for hospitalsphysician practiceshealthcare facilitiespatient care settings and clinical research facilities for inspection and verification of medication and for use in the management of electronic storage of data; Providing temporary use of non-downloadable software for audit of stored data; Non-downloadablecloud-based software as a service (SaaS) for use in inspection and verification of medication
Classe 44
Providing information over a global computer network in the field of health care; Maintaining files and records concerning medication administered to individuals; Maintaining personal medical history records and files
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/08/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/08/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/05/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
27/03/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
26/03/2020
IUAA
USE AMENDMENT ACCEPTED
26/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/02/2020
GNRT
NON-FINAL ACTION E-MAILED
21/02/2020
CNRT
NON-FINAL ACTION WRITTEN
21/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/07/2019
GNRT
NON-FINAL ACTION E-MAILED
30/07/2019
CNRT
NON-FINAL ACTION WRITTEN
30/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2019
ALIE
ASSIGNED TO LIE
08/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2019
GNRT
NON-FINAL ACTION E-MAILED
05/01/2019
CNRT
NON-FINAL ACTION WRITTEN
05/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/11/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
30/11/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/06/2018
GNRT
NON-FINAL ACTION E-MAILED
07/06/2018
CNRT
NON-FINAL ACTION WRITTEN
07/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/05/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2018
GNRT
NON-FINAL ACTION E-MAILED
09/02/2018
CNRT
NON-FINAL ACTION WRITTEN
09/02/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2018
ALIE
ASSIGNED TO LIE
16/01/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
30/12/2017
IUAF
USE AMENDMENT FILED
30/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/12/2017
EAAU
TEAS AMENDMENT OF USE RECEIVED
29/12/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/11/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/11/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2017
GNRT
NON-FINAL ACTION E-MAILED
04/10/2017
CNRT
NON-FINAL ACTION WRITTEN
04/10/2017
DOCK
ASSIGNED TO EXAMINER
27/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2017
NWAP
NEW APPLICATION ENTERED
04/07/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARMID ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.